BlackLine BL 深 沪
等待开盘 07-08 09:30:00 美东时间
29.02
-0.080
-0.27%
华盛通- 最 高30.15
- 今 开29.78
- 成交量 77.61万股
- 最 低 29.00
- 昨 收 29.10
- 总市值 17.02亿
- 52周最高 59.57
- 市盈率 静 74.76
- 换手率 1.32%
- 52周最低 24.70
- 委 比 -82.14%
- 总股本 5866.09万
- 历史最高 154.61
- 量 比 0.73
- 振 幅 3.95%
- 历史最低 21.715
- 每 手 1
- 风险率 11.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Blackline Safety Q2 EPS $(0.04) Misses $(0.01) Estimate, Sales $44.293M Beat $41.040M Estimate
Blackline Safety (TSX:BLN) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.01) by 300 percent. This is unchanged from the same period last year. The company reported quarterly sales of $44.293 million which beat the analyst consensus estimate of $41....
06-10 19:34
Blackline Safety publishes MD&A for three and six months ended April 30, 2026
Blackline Safety publishes MD&A for three and six months ended April 30, 2026 Blackline Safety published its MD&A for fiscal Q2, showing revenue of CAD 44,293, up 23% driven by service growth. Service revenue rose 25% to CAD 27,317; product revenue increased 21% to CAD 16,976 on initial G8 shipments
06-10 19:20
Nu Holdings Announces $1 Billion Share Buyback As Shares Rise
Nu Holdings shares rose after the company approved a $1 billion share repurchase program to enhance shareholder value.
06-05 00:25
Taiwan Semiconductor CEO Says Rivals Have Years To Catch Up
Taiwan Semiconductor (TSM) stock slips 2% in premarket trading as investors take profits. See why analysts remain bullish on the chip giant.
06-04 18:40
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Taiwan Semiconductor's Arizona Chip Hub Thrives, But Power And Labor Risks Persist
Taiwan Semiconductor Arizona operations beat expectations. Here's a look at the latest technical analysis and analyst ratings.
05-12 17:37
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
财报速睇 | BlackLine, Inc. 2026财年Q1营收1.83亿美元，同比增长9.7%；归母净利润0.08亿美元，同比增长34.2%
华盛资讯5月8日讯，BlackLine, Inc.公布2026财年Q1业绩，公司Q1营收1.83亿美元，同比增长9.7%，归母净利润0.08亿美元，同比增长34.2%。
05-08 08:20
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Piper Sandler Maintains Neutral on BlackLine, Raises Price Target to $37
Piper Sandler analyst Billy Fitzsimmons maintains BlackLine (NASDAQ:BL) with a Neutral and raises the price target from $35 to $37.
05-06 17:23
